Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.20.2
STOCKHOLDERS' EQUITY (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 14, 2020
Jun. 03, 2020
May 06, 2020
Jan. 31, 2020
Aug. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Dec. 31, 2018
Dec. 31, 2019
Sep. 28, 2018
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Preferred stock, authorized           5,000,000   5,000,000   10,000,000  
Preferred stock, par value (in Dollars per share)           $ 0.0001   $ 0.0001   $ 0.0001  
Preferred stock, shares Issued                
Preferred stock, shares outstanding                
Certificate of designation series A preferred stock 5,000,000                    
Percentage purchase price 25.00%                    
Effective interest rate 25.00%                    
Stockholder debt term 1 year                    
Common stock, authorized           350,000,000   350,000,000   350,000,000  
Common stock, par value (in Dollars per share)           $ 0.0001   $ 0.0001   $ 0.0001  
Common stock, outstanding           59,388,085   59,388,085   59,268,085  
Common stock, issued           59,388,085   59,388,085   59,268,085  
Number of shares to purchase by stock option       19,625 24,428,681            
Amount of shares to purchase by stock option (in Dollars)       $ 15,479   $ 4,217,969 $ 5,268,333        
Restricted stock purchase   3,000,000                  
2018 Equity Incentive Plan [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Common stock reserved for issuance           10,000,000   10,000,000      
Preferred Stock [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Preferred stock, authorized           10,000,000   10,000,000      
Preferred stock, par value (in Dollars per share)           $ 0.0001   $ 0.0001      
Preferred stock, shares Issued           5,000,000   5,000,000      
Preferred stock, shares outstanding           5,000,000   5,000,000      
Amount of shares to purchase by stock option (in Dollars)           $ 222        
Common Stock [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Common stock, authorized           350,000,000   350,000,000      
Common stock, par value (in Dollars per share)           $ 0.0001   $ 0.0001     $ 0.0001
Common stock, outstanding           59,388,085   59,388,085      
Common stock, issued           59,388,085   59,388,085      
Amount of shares to purchase by stock option (in Dollars)           $ 243        
Warrants [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Vesting period     5 years                
Stock compensation expense (in Dollars)           0   $ 83,654      
Warrants outstanding               5,639,167      
Weighted-average contractual remaining life               2 years 4 months 24 days      
Exercise prices decrease (in Dollars per share)               $ 0.01      
Exercise prices increase (in Dollars per share)               3.25      
Weighted average exercise price (in Dollars per share)               $ 3.05      
Stock Options [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Stock compensation expense (in Dollars)           $ 81,174   $ 833,959      
Stock options to purchase     1,499,000     1,499,000   1,499,000      
Stock options exercise price (in Dollars per share)     $ 2.13                
Weighted-average contractual remaining life               9 years 7 months 6 days      
Stock option exercise price, decrease (in Dollars per share)               $ 2.13      
Unrecognized compensation expense (in Dollars)           $ 301,216   $ 301,216      
Expected weighted average vesting period               1 year 7 months 6 days      
Securities Purchase Agreement [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Agreement, description the Company entered into securities purchase agreements (the “2020 Purchase Agreements”) with certain purchasers (the “2020 Investors”), which provided for the sale of an aggregate of $4,435,000 and the exchange for debt of $265,779 of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred”) at a purchase price of $2.00 per share (the “Purchase Price”) (the “Offering”). On August 14, 2020 and August 27, 2020, pursuant to the 2020 Purchase Agreements, the Company issued an aggregate of 2,350,390 shares of Series A Preferred to the Investors (collectively the “2020 Closing”). In connection with the 2020 Closing, Eric Brock, the Company’s Chief Executive Officer purchased 157,500 shares of Series A Preferred. The aggregate gross proceeds to the Company from the 2020 Closing was $4,700,779. After payment of offering expenses, the net proceeds to the Company from the 2020 Closing was $4,483,749.                    
Issue Price One [Member] | Warrants [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Warrants to purchase shares     143,750                
Warrants exercise price (in Dollars per share)     $ 2.50                
Issue Price Two [Member] | Warrants [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Warrants to purchase shares     29,375                
Warrants exercise price (in Dollars per share)     $ 2.13                
Issue Price Three [Member] | Stock Options [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Number of shares to purchase by stock option     694,625                
Issue Price Three [Member] | Warrants [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Warrants to purchase shares     694,625                
Warrants exercise price (in Dollars per share)     $ 2.50                
Restricted Stock Units (RSUs) [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Vesting period               2 years      
Stock compensation expense (in Dollars)           1,050,000   $ 2,100,000      
Unrecognized compensation expense (in Dollars)           $ 6,300,000   $ 6,300,000      
Restricted stock purchase                 378,478    
Shares options issued non-vested           2,250,000   2,250,000      
Weighted average grant-date fair value of exercise price (in Dollars per share)               $ 2.80      
Weighted-average contractual remaining life               1 year 6 months      
Weighted average grant-date fair value (in Dollars per share)               $ 0.22      
Vesting period               2 years      
Consultant [Member] | Restricted Stock Units (RSUs) [Member]                      
STOCKHOLDERS' EQUITY (Details) [Line Items]                      
Stock compensation expense (in Dollars)           $ 10,117   $ 30,357